Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
*Cistanche tubulosa* is a medicinal herb widely utilized in Traditional Chinese Medicine (TCM), particularly for treating kidney deficiency and neurodegenerative disorders. The herb contains potent bioactive phenylethanoid glycosides, such as echinacoside and verbascoside, which have demonstrated significant neuroprotective and anti-apoptotic properties in models of Parkinson's disease (PD) and Alzheimer's disease. Its therapeutic mechanism involves the induction of endogenous neurotrophic factors, specifically glial cell-derived neurotrophic factor (GDNF), and the regulation of the nigrostriatal dopaminergic system. Research conducted by institutions like the Fujian University of Traditional Chinese Medicine suggests that nanopowder formulations of the herb can improve behavioral deficits and increase dopamine levels by protecting neurons from oxidative stress and toxin-induced damage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cistanche tubulosa.